Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S3 from NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
  1. Home
  2. Publications
  3. Figure S3 from NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs

Figure S3 from NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs

Authors:
  • BDBowen Dong
    Bowen Dong
  • NONataša Obermajer
    Nataša Obermajer
  • TTTakemasa Tsuji
    Takemasa Tsuji
  • JMJunko Matsuzaki
    Junko Matsuzaki
  • CBCindy M. Bonura
    Cindy M. Bonura
  • CSCindy Sander
    Cindy Sander
  • HWHenry Withers
    Henry Withers
  • MLMark D. Long
    Mark D. Long
  • CCColin Chavel
    Colin Chavel
  • SOScott H. Olejniczak
    Scott H. Olejniczak
  • HMHans Minderman
    Hans Minderman
  • John M. Kirkwood
    John M. Kirkwood

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.32698484
Abstract
DC-primed MART-1-specific CTLs express high levels of NKRs, but recognize and kill cancer cells in a strictly TCR-dependent manner.
Keywords
  • IMMUNOLOGY
  • IMMUNE RESPONSES TO CANCER
  • TUMOR ANTIGENS/NEOANTIGENS
  • TUMOR RESISTANCE TO IMMUNE RESPONSE
  • IMMUNOTHERAPY
  • CELLULAR IMMUNOTHERAPY
  • COMBINATION IMMUNOTHERAPY
  • SKIN CANCERS
  • MELANOMA
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.